Search by Drug Name or NDC
NDC 61958-1003-01 Ranexa 500 mg/1 Details
Ranexa 500 mg/1
Ranexa is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is RANOLAZINE.
MedlinePlus Drug Summary
Ranolazine is used alone or with other medications to treat chronic angina (ongoing chest pain or pressure that is felt when the heart does not get enough oxygen). Ranolazine is in a class of medications called anti-anginals. The exact way that ranolazine works is not known at this time.
Related Packages: 61958-1003-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ranolazine
Product Information
| NDC | 61958-1003 |
|---|---|
| Product ID | 61958-1003_ba1f4469-5e3c-447a-9d28-8e57a2c32a17 |
| Associated GPIs | 32200040007420 |
| GCN Sequence Number | 060333 |
| GCN Sequence Number Description | ranolazine TAB ER 12H 500 MG ORAL |
| HIC3 | A2C |
| HIC3 Description | ANTIANGINAL, ANTI-ISCHEMIC AGENTS,NON-HEMODYNAMIC |
| GCN | 26459 |
| HICL Sequence Number | 033446 |
| HICL Sequence Number Description | RANOLAZINE |
| Brand/Generic | Brand |
| Proprietary Name | Ranexa |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | RANOLAZINE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | RANOLAZINE |
| Labeler Name | Gilead Sciences, Inc. |
| Pharmaceutical Class | Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021526 |
| Listing Certified Through | 2022-12-31 |
Package
NDC 61958-1003-01 (61958100301)
| NDC Package Code | 61958-1003-1 |
|---|---|
| Billing NDC | 61958100301 |
| Package | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (61958-1003-1) |
| Marketing Start Date | 2006-01-27 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 6.59827 |
| Pricing Unit | EA |
| Effective Date | 2022-09-21 |
| NDC Description | RANEXA ER 500 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis